Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FE 999049 (follitropin delta) in men with idiopathic infertility
2021-004254-37Phase 2Active
- Sponsor
- Ferring Pharmaceuticals
- Start
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in unexplained male infertility (UMI) and male infertility comparing follitropin delta with placebo (2 arms). Primary endpoint: Spontaneous vital pregnancy within 9 months. Started Feb 2022; status: active.
02
Drugs
follitropin delta
03
Conditions
unexplained male infertility (UMI)male infertility
Beyond the preview
Go deeper on 2021-004254-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004254-37.